Your browser doesn't support javascript.
loading
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells.
Dwyer, Connor J; Arhontoulis, Dimitrios C; Rangel Rivera, Guillermo O; Knochelmann, Hannah M; Smith, Aubrey S; Wyatt, Megan M; Rubinstein, Mark P; Atkinson, Carl; Thaxton, Jessica E; Neskey, David M; Paulos, Chrystal M.
Afiliación
  • Dwyer CJ; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Arhontoulis DC; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Rangel Rivera GO; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Knochelmann HM; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Smith AS; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Wyatt MM; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Rubinstein MP; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Atkinson C; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Thaxton JE; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
  • Neskey DM; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Paulos CM; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA.
Eur J Immunol ; 50(9): 1386-1399, 2020 09.
Article en En | MEDLINE | ID: mdl-32383488
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfocitos T CD8-positivos / Fosfatidilinositol 3-Quinasa Clase I / Fosfatidilinositol 3-Quinasa Clase Ib Tipo de estudio: Guideline Límite: Animals / Humans Idioma: En Revista: Eur J Immunol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfocitos T CD8-positivos / Fosfatidilinositol 3-Quinasa Clase I / Fosfatidilinositol 3-Quinasa Clase Ib Tipo de estudio: Guideline Límite: Animals / Humans Idioma: En Revista: Eur J Immunol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania